Showing results (651-660 of 1,904) with videos related to
Sort By:
Pageof 191
Current Neuropharmacology|September 29, 2015
The Neurobiological Mechanisms and Treatments of REM Sleep Disturbances in DepressionYi-Qun Wang, Rui Li, Meng-Qi Zhang, et al.Current Neuropharmacology|October 25, 2014
EDITORIAL Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic InterventionLiang Peng, Vladimir Parpura, Alexei VerkhratskyCurrent Neuropharmacology|October 25, 2014
Antagonists of the Vasopressin V1 Receptor and of the β(1)-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes - but the Mechanisms DifferLeif Hertz, Junnan Xu, Ye Chen, et al.Current Neuropharmacology|October 25, 2014
Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic EffectsLiang Peng, Li Gu, Baoman Li, et al.Current Neuropharmacology|October 25, 2014
Neurodegeneration in diabetic retina and its potential drug targetsMohammad Shamsul Ola, Abdullah S AlhomidaCurrent Neuropharmacology|November 27, 2014
Agomelatine in the treatment of major depressive disorder: an assessment of benefits and risksMaximilian GahrCurrent Neuropharmacology|January 15, 2020
Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief ReviewNeha Dhir, Bikash Medhi, Ajay Prakash, et al.Current Neuropharmacology|November 20, 2020
The Brain-gut Axis-where are we now and how can we Modulate these Connections?Wojciech Dabrowski, Dorota Siwicka-Gieroba, Katarzyna Kotfis, et al.Current Neuropharmacology|November 12, 2020
Mimicking Extracellular Matrix via Engineered Nanostructured Biomaterials for Neural RepairAndrea Raspa, Fabrizio GelainCurrent Neuropharmacology|September 5, 2020
A Scientometrics Analysis and Visualization of Depressive DisorderDong Xu, Yi-Lun Wang, Kun-Tang Wang, et al.Pageof 191